DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A strong ...

In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

DexCom, Inc. (DXCM), with a market cap of $33.9 billion, is a leading medical device company specializing in continuous ...

DexCom Inc. closed 34.58% short of its 52-week high of $132.26, which the company reached on May 17th.

Dexcom Inc. defeated investor allegations the glucose monitor maker exaggerated its ability to tap into the market of ...

Shares of DexCom Inc. DXCM shed 1.11% to $84.11 Tuesday, on what proved to be an all-around mixed trading session for the ...

After this recent quarterly performance and the resultant increase in stock price, an important question arises: is DXCM ...

The medical instruments industry is currently undergoing a transformative phase, thanks to the rapid adoption of generative ...

SAN DIEGO, May 13, 2025--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose biosensing, today announced the promotion of Jake Leach to president ...

(RTTNews) - DexCom, Inc. (DXCM) announced Tuesday the promotion of Jacob Leach to president, in addition to his current role as chief operating officer, which he has held since 2022. With more ...

The Oura Ring 4 is rapidly becoming the center piece of your efforts to lead a healthier life, and the introduction of two ...